Current US legislation on the environmental, health and safety impact of nanomaterials in coating products

Table of Contents

1. Introduction

1.1 Background of the study

1.1.1 Nanotechnology

1.1.2 Coatings

1.1.3 Risk Regulations & Nanotechnology

1.2 Aim & Objectives of the Study

1.3 Boundaries of the study

2. Nanomaterials in Coatings in the USA Market

2.1 Nanomaterial Types Used in Coatings

2.2 Functional Benefits of Nanotechnology-based Coatings

3. Risks Posed by Coatings containing Nanomaterials

3.1 Hazards of Nanomaterials used in Coatings

3.2 Potential Releases

3.2.1 Potential Releases from the Nanomaterial Manufacturing Stage

3.2.2 Potential releases during the Material Processing Stage & NM-Coating Manufacturing

3.2.3 Potential Release of NMs from Coating Applications during Use Stage

3.2.4 Potential Release during the Incineration, Land-filling & Waste Water Treatment Stage

4. Life Cycle Regulations of Nanocoatings

4.1 Horizontal Issues across all Regulations

4.1.1 Absence of Nano-Definition

4.1.2 Failure of Reporting of Nanomaterials in Commercial Use and Fuzzy Commercialization Paths

4.1.3 No Standardized Methods

4.1.4 Poor Risk Communication

4.2 Pre-market Stage Regulations

4.2.1 TSCA Regulatory Issues

4.2.2 Ineffective Characterization at Different Life Cycle Stages

4.2.3 Federal Insecticide, Fungicide, and Rodenticide Regulatory Issues

4.3 Use Stage Regulations

4.3.1 Consumer Product Safety Act Issues

4.4 End of Life Regulations

4.4.1 Resource Conservation and Recovery Act Issues

4.4.2 The Comprehensive Environmental Response, Compensation, and Liability Act Regulatory Issues

4.5 Regulations along Lifecycle

4.5.1 OSHAct Issues

4.5.2 Clean Air Act & Clean Water Act Issues

5. Analysis & Discussion

5.1 Analysis

5.2 Discussion

6. Conclusions

Research Objectives and Key Topics

This thesis examines the adequacy of the existing US federal regulatory system to manage potential environmental, health, and safety risks associated with the use of nanomaterials in coating products across their entire life cycle. The research aims to identify regulatory gaps, evaluate the effectiveness of different statutes, and provide a prioritization for necessary regulatory amendments.

• Analysis of nanomaterial release mechanisms throughout the life cycle of coating products.
• Evaluation of major US federal regulatory frameworks (TSCA, FIFRA, CPSA, RCRA, CERCLA, OSHAct, CAA, CWA).
• Identification of horizontal regulatory issues such as the absence of a nano-definition and standardized measurement methods.
• Assessment of the effectiveness of each regulatory framework in triggering risk reviews and managing potential hazards.

Excerpt from the Book

Summary of Chapters

1. Introduction: Outlines the scope of nanotechnology in coatings and establishes the necessity for investigating the adequacy of US federal regulations for managing nanomaterial-related risks.

2. Nanomaterials in Coatings in the USA Market: Provides an overview of nanomaterials used in the US coating industry and discusses their functional benefits and commercial importance.

3. Risks Posed by Coatings containing Nanomaterials: Analyzes the hazards associated with nanomaterials and evaluates potential exposure scenarios through different stages of the life cycle, including production, use, and disposal.

4. Life Cycle Regulations of Nanocoatings: Presents a detailed review of US federal statutes and their applicability to nanomaterials, identifying critical horizontal issues and framework-specific challenges.

5. Analysis & Discussion: Uses a scoring system based on specific criteria to evaluate the effectiveness of the reviewed regulatory frameworks in managing safety and identifies those that are most problematic.

6. Conclusions: Synthesizes the study's findings, concluding that the current US regulatory system is poorly equipped to address nanomaterial risks and highlighting the need for systemic improvements and further research.

Keywords

Nanotechnology, Nanomaterials, Coatings, US Federal Regulations, EHS, TSCA, Risk Assessment, Life Cycle, Nanocoatings, Toxicology, Exposure, Environmental Policy, Regulatory Oversight, Hazard Identification, Nanowaste

Frequently Asked Questions

What is the primary focus of this dissertation?

This work evaluates whether current US federal regulations are adequate to manage the environmental, health, and safety risks posed by nanomaterials used in coating products throughout their entire life cycle.

What are the central thematic fields covered in the study?

The study focuses on the intersection of nanotechnology applications in coatings, the toxicological hazards of these materials, and the legal frameworks currently governing chemical substances in the United States.

What is the primary research goal?

The goal is to determine the effectiveness of existing US regulatory frameworks in managing nanomaterial risks and to prioritize which statutes require the most urgent amendment to provide better oversight.

Which scientific methods were employed to reach the conclusions?

The research uses a life cycle analysis approach, reviewing federal statutes, governmental and academic studies, and applying a qualitative scoring system based on specific adequacy criteria for each regulatory framework.

What does the main body of the work cover?

The main part of the thesis covers the types of nanomaterials used in coatings, scenarios for their potential release into the environment, and a comprehensive legal review of various acts like TSCA, RCRA, and OSHAct regarding their specific application and limitations concerning nanomaterials.

Which keywords best characterize this research?

Key terms include Nanotechnology, Nanomaterials, Coatings, US Federal Regulations, EHS, TSCA, Risk Assessment, Life Cycle, and Regulatory Oversight.

Why are RCRA and CPSA identified as particularly problematic regulations?

These frameworks are identified as least effective because they suffer from narrow applicability, lack of specific mechanisms to address chronic nanomaterial risks, and significant data gaps that prevent them from triggering proactive risk reviews.

What is the role of FIFRA in this context?

FIFRA is highlighted as the most adequate regulatory framework among those studied, as it provides a clearer basis for managing nanomaterial risks, specifically for antimicrobial-treated products, and requires data generation prior to commercialization.